{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:22:36Z","timestamp":1785792156005,"version":"3.56.0"},"reference-count":41,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Acta Clinica Belgica"],"published-print":{"date-parts":[[2023,5,4]]},"DOI":"10.1080\/17843286.2022.2114684","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T08:40:44Z","timestamp":1661244044000},"page":"215-222","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Truth or dare: switching BRAF\/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma \u2013 A case report and review of the literature"],"prefix":"10.1080","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2114-2051","authenticated-orcid":false,"given":"Lore","family":"De Ryck","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"Delanghe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharareh","family":"Fadaei","sequence":"additional","affiliation":[{"name":"Department of Anatomopathology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Brochez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saerens","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.02.021"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30700-9"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30388-2"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109970"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz411"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30593"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-85"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1210093"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904059"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30122-X"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.11.016"},{"key":"cit0012","unstructured":"SERVICES USDOHAH. Common terminology criteria for adverse events (CTCAE) 2017. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_8.5x11.pdf"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12555"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1713"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv149"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000186"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa372"},{"issue":"7","key":"cit0018","doi-asserted-by":"crossref","first-page":"e1520","DOI":"10.1002\/cnr2.1520","volume":"5","author":"Krelle A","year":"2021","journal-title":"Cancer rep"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0456"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.9533"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.9534"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000491"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061650"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000493"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2020.01.012"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2016.1164139"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28709"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007196"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3086-7"},{"key":"cit0030","unstructured":"European Medicines Agency. Tafinlar. annex 1: summary of product characteristics 2013 [updated 2021 Dec 09]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tafinlar-epar-product-information_en.pdf"},{"key":"cit0031","unstructured":"European Medicines Agency. Zelboraf. annex 1: summary of product characteristics 2012 [updated 2021 Nov 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zelboraf-epar-product-information_en.pdf"},{"key":"cit0032","unstructured":"European Medicines Agency. Braftovi. annex 1: summary of product characteristics 2018 [updated 2022 Jan 28]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/braftovi-epar-product-information_en.pdf"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00345.2007"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149873"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.12.013"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000122"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.89"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01390118"},{"issue":"3","key":"cit0039","first-page":"228","volume":"15","author":"Kleinknecht D","year":"1995","journal-title":"Semin Nephrol"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019070676"},{"key":"cit0041","unstructured":"ClinicalTrials.gov. Studies found for: dabrafenib and trametinib OR encorafenib and binimetinib OR vemurafenib and cobimetinib [updated 2022 Mar 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=dabrafenib+and+trametinib+OR+encorafenib+and+binimetinib+OR+vemurafenib+and+cobimetinib&cntry=&state=&city=&dist=&Search=Search&type=Intr"}],"container-title":["Acta Clinica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17843286.2022.2114684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T02:31:43Z","timestamp":1700965903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17843286.2022.2114684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5,4]]}},"alternative-id":["10.1080\/17843286.2022.2114684"],"URL":"https:\/\/doi.org\/10.1080\/17843286.2022.2114684","relation":{},"ISSN":["1784-3286","2295-3337"],"issn-type":[{"value":"1784-3286","type":"print"},{"value":"2295-3337","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yacb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yacb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}